SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-432802
Filing Date
2013-11-07
Accepted
2013-11-07 16:08:07
Documents
2
Period of Report
2013-11-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d626507d8k.htm 8-K 15116
2 EX-99.1 d626507dex991.htm EX-99.1 43118
  Complete submission text file 0001193125-13-432802.txt   59446
Mailing Address 1522 217TH PLACE S.E. BOTHELL WA 98021
Business Address 1522 217TH PLACE S.E. BOTHELL WA 98021 4254879500
ONCOGENEX PHARMACEUTICALS, INC. (Filer) CIK: 0000949858 (see all company filings)

IRS No.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 033-80623 | Film No.: 131200680
SIC: 2835 In Vitro & In Vivo Diagnostic Substances